LipAgg
Doctoral Network
on Amyloid Protein
Doctoral Network
on Amyloid Protein
MSCA participants are expected to explain the actions they are taking to address the sustainability of their research projects in their proposals and at final reporting stage.
Sustainability can play a role as an additional criterion in the evaluation of ex-aequo proposals.
To help participants better understand how they can integrate sustainability concerns into projects in practice, the charter and its supporting material offer practical recommendations covering topics such as :
While the relevance of the charter’s principles and recommendations may vary depending on the MSCA participants and projects, the guidance documents are there to help everyone find the resources they need depending on their own situation.
I am a researcher at the Institute of Chemistry and Biology of Membranes and Nano-Objects (CBMN, CNRS, France).
I joined CNRS in 2009 after receiving my PhD in Physical Chemistry from the University of Bordeaux (France) and completing postdoctoral training at Université Paris Cité (France, UMR 8601) under the supervision of Prof. Dr. Isabelle Artaud and at Utrecht University under the supervision of Prof. Dr. J. Antoinette Killian (the Netherlands).
My current research focuses on the molecular mechanisms of amyloid-forming proteins and on the interactions between amyloid proteins and membranes, ranging from artificial membranes to cellular membranes. I am particularly interested in islet amyloid polypeptide, which is associated with type 2 diabetes.
I am the coordinator of the Horizon Europe Marie Skłodowska-Curie Actions Doctoral Network LipAgg project.